Among patients with early stage breast cancer, breast-conserving therapy with radiation appears to be associated with a better disease-specific survival (DSS) when compared with mastectomy. A large investigation revealed that DSS results were greater among women aged 50 and older with hormone receptor (HR)-positive disease than for younger women with HR-negative disease.

Abstract: Cancer, April 1, 2013.